Analysts' recommendations: Carmat SA

25-05-09	Carmat: Invest Securities raises target price
25-04-11	Carmat: Invest Securities still a buyer, but cuts TP
25-02-04	Carmat: Invest Securities slightly lowers its target
25-01-09	Carmat: Invest Securities upgrades to buy
25-01-09	Carmat: Oddo BHF reduces its price target

More recommendations

News in other languages: Carmat SA

Mar. 04	Carmat, Ynsect… quand les pépites industrielles françaises tombent dans le gouffre de Moore
Jan. 07	Pluxee N : Carmat, Hoffmann, LDC, Pluxee, Technip Energies... les valeurs à suivre aujourd'hui à Paris
Jan. 07	Bourse : GTT et Technip Energy engrangent, Pluxee publie, Carmat disparaît
Jan. 07	CARMAT : A suivre aujourd'hui
Jan. 07	Les records continuent à tomber en bourse

More news

Managers and Directors: Carmat SA

Manager	Title	Age	Since
Stéphane Piat CEO	Chief Executive Officer	55	2016-08-31
Pascale d’Arbonneau DFI	Director of Finance/CFO	-	2018-12-11
Christian Latrémouille CTO	Chief Tech/Sci/R&D Officer	-	2025-03-31

Director	Title	Age	Since
Stéphane Piat BRD	Director/Board Member	55	-
Jean-Luc Lemercier BRD	Director/Board Member	68	2017-01-01
Michael Mack BRD	Director/Board Member	79	2017-04-19

More insiders

Carmat SA, formerly known as Carmat SAS is a France-based company engaged in the development and production of heart prosthesis. The Company is developing an orthotopic and biocompatible artificial heart which works like a natural heart, and which is hydraulically activated. It specializes in the development of a fully implantable orthotopic artificial heart, its electrical power supply system, and its telediagnosis system. The Company formed a network of partnerships with hospitals and various scientific companies, such as The Georges Pompidou European Hospital, The Marie Lannelongue Surgical Center, The Hospital Charles Nicolle of Rouen, Dedienne Sante, PaxiTech, Vignal Artru Industries, French Vessels, and Blood Institute, Laboratoire de Recherche Biochirurgicale and others.

Employees

153

Sector

Medical Equipment, Supplies & Distribution

More about the company

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States

Canada

Market Closed - Euronext Paris 2026-03-20			5-day change	1st Jan Change
0.0990 ^EUR	-.--%		-.--%	-

Sep. 01	CARMAT SAS Publishes Results Of EFICAS Clinical Study On Aeson Total Artificial Heart As Bridge-To-Transplant Therapy	CI
Jan. 07	Carmat, Hoffmann, LDC, Pluxee, Technip Energies... Stocks to Watch Today in Paris

Market Cap	6.15M 6.89M 5.73M 5.21M 9.81M 663M 9.89M 69.18M 26.92M 339M 25.86M 25.3M 1.09B	P/E 2023	-3.09x	P/E 2024	-0.95x
Enterprise Value	59.25M 66.41M 55.2M 50.23M 94.59M 6.4B 95.29M 667M 259M 3.26B 249M 244M 10.49B	EV / Sales 2023	56.1x	EV / Sales 2024	13.5x
Free-Float	89.06%	Yield 2023 *	-	Yield 2024	-

Sep. 01	CARMAT SAS Publishes Results Of EFICAS Clinical Study On Aeson Total Artificial Heart As Bridge-To-Transplant Therapy	CI
Jan. 07	Carmat, Hoffmann, LDC, Pluxee, Technip Energies... Stocks to Watch Today in Paris
Jan. 07	CARMAT: To Watch Today
Jan. 06	Carmat, GTT, Genfit, LDC... Stocks to Watch Tomorrow in Paris
Jan. 06	Carmat Announces Liquidation and Delisting
Dec. 02	Only Takeover Bid for Carmat Approved by Court
Dec. 02	Carmat: Takeover Offer Approved, 88 Jobs Saved	RE
Dec. 02	Carmat receives takeover bid	RE
Nov. 04	Carmat SAS submits bid for Carmat SA within ongoing receivership procedure	RE
25-10-15	CAC 40 Surges on LVMH Results and Easing US-China Tensions
25-10-15	Carmat: Judicial Recovery Continues, New Hearing Set for November 25	RE
25-10-15	Carmat says liquidation review postponed until Nov 25	RE
25-10-01	Carmat: Judicial Liquidation Request to Be Reviewed on October 14	RE

Dec. 02	CARMAT Provides an Update on the Ongoing Receivership Procedure	BU
Nov. 04	CARMAT Provides an Update on the Ongoing Receivership Procedure	BU
25-10-29	CARMAT : Inside Information / Other news releases	PU
25-10-29	CARMAT Announces Postponing the Publication of its 2025 Interim Financial Report (Six Months Ended June 30, 2025)	BU
25-10-15	CARMAT Provides an Update on the Ongoing Receivership Procedure	BU

Carmat SA Stock

Stocks

ALCAR

FR0010907956

Medical Equipment, Supplies & Distribution

Valuation: Carmat SA

Chart: Carmat SA

Latest news: Carmat SA

Analysts' recommendations: Carmat SA

Press Releases: Carmat SA

News in other languages: Carmat SA

Price Extremes

Managers and Directors: Carmat SA

Latest insider transactions

Medical Devices & Implants

Financials

Company Profile

Current year	0.1	0.1
1 year	0.1	0.1
3 years	0.08	9.99
5 years	0.08	29.5
10 years	0.08	40.06

Date	Insider	Type	Main position	Quantity	% Market Cap.
3/13/25	Pierre Bastid	Sell	Chairman	1,343,333	2.3347%
3/13/25	Pierre Bastid	Buy	Chairman	1,343,333	2.3347%
5/29/24	Antonino Ligresti	Buy	Director	1,343,333	4.6122%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CARMAT SA	-.--%	-.--%	-.--%	-97.84%	7.08M
ABBOTT LABORATORIES	+2.70%	-0.49%	-24.86%	+4.46%	169B
MEDTRONIC PLC	+1.76%	-1.74%	-10.66%	+15.48%	110B
STRYKER CORPORATION	+3.28%	+3.25%	-22.39%	+7.34%	106B
ESSILORLUXOTTICA	+1.19%	-1.10%	-47.66%	-11.35%	73.87B
CENCORA, INC.	+1.74%	+3.49%	+2.99%	+69.92%	58.98B
HOYA CORPORATION	+1.32%	+4.32%	+14.41%	+64.37%	51.28B
BECTON, DICKINSON AND COMPANY	+1.97%	-2.01%	-6.18%	-31.00%	48.16B
IDEXX LABORATORIES, INC.	+1.72%	-0.15%	-15.86%	+22.70%	40.84B
DEXCOM, INC.	+1.77%	+0.12%	+30.77%	+3.31%	32.21B
Average	+1.75%	-0.77%	-7.94%	+4.74%	69.02B
Weighted average by Cap.	+2.14%	-1.30%	-14.92%	+13.57%

	2023	2024
Net sales	3.84M 4.3M 3.57M 3.25M 6.13M 414M 6.17M 43.19M 16.81M 211M 16.15M 15.8M 680M	7.34M 8.23M 6.84M 6.23M 11.73M 793M 11.81M 82.67M 32.17M 405M 30.9M 30.24M 1.3B
Net income	-53.87M -60.38M -50.19M -45.67M -86.01M -5.82B -86.65M -606M -236M -2.97B -227M -222M -9.54B	-51.4M -57.61M -47.88M -43.57M -82.06M -5.55B -82.67M -579M -225M -2.83B -216M -212M -9.1B
Net Debt	49.64M 55.64M 46.24M 42.08M 79.25M 5.36B 79.84M 559M 217M 2.73B 209M 204M 8.79B	53.1M 59.52M 49.47M 45.02M 84.78M 5.73B 85.41M 598M 233M 2.93B 223M 219M 9.4B